1
/
of
1
ELK Biotechnology
SKU:ELK8379
Mouse 8-iso-PGF2α(8-isoprostane)ELISA Kit
Mouse 8-iso-PGF2α(8-isoprostane)ELISA Kit
Regular price
$458.00 USD
Regular price
Sale price
$458.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Mouse 8-iso-PGF2α(8-isoprostane)ELISA Kit
Overview
| Product name: | Mouse 8-iso-PGF2α(8-isoprostane) ELISA Kit |
| Reactivity: | Mouse |
| Alternative Names: | 8-isoprostane; 8-iso-PGF2α |
| Assay Type: | Competitive Inhibition |
| Sensitivity: | 9.375 pg/mL |
| Standard: | 1000 pg/mL |
| Range: | 15.625-1000 pg/mL |
| Sample Type: | serum, plasma and other biological fluids |
| Assay Length: | 2h |
| Research Area: | Endocrinology;Pulmonology;Hepatology;Hormone metabolism; |
| Test principle: | This assay employs the competitive inhibition enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with Mouse 8-iso-PGF2α protein. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Mouse 8-iso-PGF2α. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Mouse 8-iso-PGF2α in the samples is then determined by comparing the OD of the samples to the standard curve. |
Standard curve
| Concentration (ng/mL) | OD | Corrected OD |
|---|---|---|
| 1000.00 | 0.237 | — |
| 500.00 | 0.332 | — |
| 250.00 | 0.577 | — |
| 125.00 | 0.842 | — |
| 62.50 | 1.127 | — |
| 31.25 | 1.565 | — |
| 15.63 | 1.869 | — |
| 0.00 | 2.028 | — |

Precision
Intra-assay Precision (Precision within an assay):CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays):CV%<10%
Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.
Recovery
Matrices listed below were spiked with certain level of recombinant 8-iso-PGF2α and the recovery rates were calculated by comparing the measured value to the expected amount of 8-iso-PGF2α in samples.
| Matrix | Recovery range | Average |
|---|---|---|
| serum(n=5) | 90-105% | 97% |
| EDTA plasma(n=5) | 87-99% | 93% |
| Heparin plasma(n=5) | 82-95% | 87% |
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of 8-iso-PGF2α and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Matrix | 1:2 | 1:4 | 1:8 | 1:16 |
|---|---|---|---|---|
| serum(n=5) | 85-94% | 87-101% | 79-96% | 85-99% |
| EDTA plasma(n=5) | 95-104% | 82-96% | 92-105% | 83-92% |
| Heparin plasma(n=5) | 95-104% | 84-98% | 95-102% | 88-102% |
Share
